Skip to content
  • Home
  • Visit our other Journals
    • VJHemOnc
    • VJOncology
    • VJNeurology
    • VJDementia
    • VJHemOnc-E
  • About
    • Supporter
    • Expert Index
    • Editorial Board
    • Editorial Team
    • Editorial Policy
  • Contact
  • Sign up

Visit

vjhemonc logo
VJRegenMed
Logo
  • Specialties
    Hematology
    Oncology
    Musculoskeletal Disorder
    Rare Disease
    Metabolic Disorder
    Cardiovascular Disease
    Ophthalmology
    Neurology
    Infectious Disease
    View all Specialties
  • Technologies
    Cell Therapy
    MSC
    iPSC
    Gene Therapy
    Genome Editing
    Extracellular Vesicles
    CAR-T Therapy
    TCR Therapy
    Tissue-Engineering & Biomaterials
    View all Technologies
  • Topics
    Treatment
    Immuno-Oncology
    Trial Updates
    Perspectives
    Manufacturing
    COVID-19
    View all Topics
  • Conferences
    ASH 2022
    TCT 2022
    Meeting on the Med 2022
    ICLE 2022
    Advanced Therapies Week 2022
    TERMIS 2021
    ESGCT 2021
    Meeting on the Mesa 2021
    Advanced Therapies 2021
    View all Conferences
    • About
      • Supporter
      • Expert Index
      • Editorial Board
      • Editorial Team
      • Editorial Policy
    • Contact
    • Sign up

allogeneic

Challenges to address in the CAR-T field 4:58
Challenges to address in the CAR-T field
John Rossi • 26 Aug 2021
Development of personalized tissue-engineered veins 2:54
Development of personalized tissue-engineered veins
Petter Björquist • 14 Oct 2021
Future advancements in tissue engineering 3:16
Future advancements in tissue engineering
Petter Björquist • 14 Oct 2021
How personalized tissue-engineered veins can overcome transplantation problems 1:10
How personalized tissue-engineered veins can overcome transplantation problems
Petter Björquist • 14 Oct 2021
ISCT 2021 highlights: therapeutic deception, global regulation & CAR-T 4:33
ISCT 2021 highlights: therapeutic deception, global regulation & CAR-T
Aaron Levine • 28 May 2021
miCAR: combining microRNA gene silencing with CAR expression 4:17
miCAR: combining microRNA gene silencing with CAR expression
Marco Alessandrini • 20 May 2021
Hypoimmunogenic iPSCs: avoiding immune rejection 5:05
Hypoimmunogenic iPSCs: avoiding immune rejection
Sonja Schrepfer • 27 May 2021
Cardiosphere-derived cells in myocardial regeneration 2:01
Cardiosphere-derived cells in myocardial regeneration
Linda Marban • 19 May 2021
Challenges in developing cord blood- and cord tissue-based therapies 3:48
Challenges in developing cord blood- and cord tissue-based therapies
Joanne Kurtzberg • 22 Jun 2021
Advances in cell-based therapies for MS 4:55
Advances in cell-based therapies for MS
Jakob Dupont • 17 Jun 2021
ATA188: an allogeneic EBV-specific T cell therapy for progressive MS 5:20
ATA188: an allogeneic EBV-specific T cell therapy for progressive MS
Jakob Dupont • 17 Jun 2021
Characterization of ATA188: an off-the-shelf therapy for MS 4:08
Characterization of ATA188: an off-the-shelf therapy for MS
Jakob Dupont • 17 Jun 2021
Optimizing blood supply chain management in cell & gene therapy 4:28
Optimizing blood supply chain management in cell & gene therapy
Delara Motlagh • 1 Jun 2021
Innovations within the CAR T-cell field 1:40
Innovations within the CAR T-cell field
Hong Ma • 19 Feb 2021
Allogenic NKX101 in r/r AML 2:56
Allogenic NKX101 in r/r AML
James Trager • 22 Feb 2021
Avoiding immune rejection of allogeneic iPSCs 3:38
Avoiding immune rejection of allogeneic iPSCs
Sonja Schrepfer • 27 May 2021
  • 1
  • 2
  • Next
Journal Pages
  • Specialties
  • Technologies
  • Topics
  • Conferences
Newsletter

Receive the latest news and videos from VJRegenMed via email

Sign up
Contact Us

Contact us for more information

mmp logo

Magdalen Centre
The Oxford Science Park
Oxford OX4 4GA, United Kingdom

VJRegenMed logo
The content of VJRegenMed is intended for healthcare professionals
  • Cookie Policy
  • Privacy Policy
  • Terms of Use
  • Editorial Policy